Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-500
Closed -$15.7K 1111
2025
Q2
$15.7K Buy
+500
New +$16.5K ﹤0.01% 943
2021
Q4
Sell
-71,938
Closed -$5.68M 1264
2021
Q3
$5.68M Buy
71,938
+48,291
+204% +$3.88M 0.02% 509
2021
Q2
$1.86M Sell
23,647
-10,051
-30% -$770K 0.01% 528
2021
Q1
$2.54M Buy
+33,698
New +$2.47M 0.01% 641
2020
Q1
Sell
-4,337
Closed -$270K 750
2019
Q4
$270K Buy
+4,337
New +$245K ﹤0.01% 769
2019
Q2
Sell
-25,182
Closed -$1.24M 798
2019
Q1
$1.24M Buy
+25,182
New +$1.1M 0.01% 554
2018
Q1
Sell
-9,773
Closed -$666K 911
2017
Q4
$666K Sell
9,773
-3,483
-26% -$235K 0.01% 558
2017
Q3
$950K Sell
13,256
-1,546
-10% -$108K 0.01% 527
2017
Q2
$1M Sell
14,802
-269
-2% -$18.3K 0.01% 405
2017
Q1
$1.02M Buy
+15,071
New +$1M 0.01% 395

Other funds holding ENOV

Natixis's ENOV Position: Q3 2025 in Review

Natixis sold out of Enovis (ENOV) in Q3 2025, closing a stake of 500 shares — an estimated $15.7K sold.

Natixis first reported a position in ENOV in Q1 2017 and held it in 10 quarters. The position peaked at $5.68M in Q3 2021. 278 funds tracked by Wall St. Rank hold ENOV as of Q3 2025.

  • Natixis reported no remaining Enovis position as of Q3 2025 after selling out during the quarter.
  • Natixis sold 500 Enovis shares in Q3 2025, an estimated $15.7K.
  • Natixis first reported a position in Enovis in Q1 2017 and held it in 10 quarters.
  • Natixis's Enovis position peaked at $5.68M in Q3 2021.
  • 278 funds tracked by Wall St. Rank held Enovis as of Q3 2025.

Based on Natixis's 13F filing for Q3 2025, filed 14 Nov 2025.